Covid Friday: Merck Not Very Effective
Who thought Big Pharma would save us?
Merck's COVID-19 pill significantly less effective in new analysis
Nov 26 (Reuters) - Merck & Co (MRK.N) said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less effective in cutting hospitalizations and deaths than previously reported.
The drugmaker said its pill showed a 30% reduction in hospitalizations and deaths, based on data from 1,433 patients. In October, its data showed a roughly 50% efficacy, based on data from 775 patients. The drug, molnupiravir, was developed with partner Ridgeback Biotherapeutics.
Who believes Pfizer now?
Meanwhile, Pfizer advertises nationally and locally, helpfully informing us that "now is a good time to get your vaccine". While the so-called President of the United States of America presses an unconstitutional mandate of their product, and OSHA issues an unconstitutional emergency order requiring their product. Who runs this country?